Global Strategies for Reducing Hepatitis C Transmission Through Treatment and Harm Reduction

Module number
 
Date presented
October 2, 2018 
Duration
41:43 
Audience
 
CE Credit
 

On Tuesday, October 2nd, Sarah Blach, MHS, CPH, Hepatitis C Team Lead and Epidemiologist for the Center for Disease Analysis (CDA) Foundation, presented on: “Global Strategies for Reducing Hepatitis C Transmission Through Treatment and Harm Reduction”

Presenter Bio:
Sarah Blach, MHS, CPH, is the Hepatitis C (HCV) Team Lead and an Epidemiologist at the Center for Disease Analysis (CDA) Foundation. Her team has analyzed and published the hepatitis epidemiology in over 100 countries and has worked with individual countries to develop national hepatitis strategies. She also leads the HCV team for the Polaris Observatory, which provides up-to-date estimates for HCV, HBV and HDV disease burden and tracks the impact of strategies to meet national targets.
Sarah holds a Master of Health Science degree in Population Environmental Health, and a Certificate in Risk Sciences, from the Johns Hopkins Bloomberg School of Public Health. She received a Bachelor of Science degree in Biomedical Science from Colorado State University. Sarah is Certified in Public Health (CPH) through the National Board of Public Health Examiners. She is widely published in the field of hepatitis, in journals such as the Lancet Gastroenterology and Hepatology, Journal of Hepatology, Journal of Viral Hepatitis, and Liver International.

Access the slides here